Methods for measuring antibody-dependent cell-mediated cytotoxicity in vitro

Area of Science:

• Immunology
• Pharmacology
• Biotechnology

Background:

• Antibody-dependent cell-mediated cytotoxicity (ADCC) is a key mechanism of action for therapeutic monoclonal antibodies (mAbs).
• ADCC involves the destruction of antibody-coated cells by effector cells expressing Fc receptors, primarily FcγRIII (CD16).
• Quantifying ADCC activity is essential for the development and evaluation of novel mAb therapeutics.

Purpose of the Study:

• To describe and validate three distinct methods for measuring the ADCC activity of monoclonal antibodies.
• To provide researchers with tools to assess different facets of the ADCC mechanism.
• To facilitate the characterization of mAb efficacy in preclinical and clinical settings.

Main Methods:

• Development and application of three quantitative assays to measure ADCC.
• Assays focus on distinct measurable aspects of the ADCC pathway.
• Validation of methods for reproducibility and sensitivity.

Main Results:

• Successful implementation of three novel methods for ADCC quantification.
• Demonstration of the ability of these methods to capture distinct biological readouts of ADCC.
• Data supporting the utility of these assays for mAb characterization.

Conclusions:

• The presented methods offer robust and versatile approaches to quantify ADCC activity.
• These assays are valuable tools for the assessment of therapeutic mAbs.
• Accurate measurement of ADCC is critical for advancing antibody-based therapies.